Protocol to Obtain Blood Samples for Leukemia Research

Dartmouth-Hitchcock Medical Center1 site in 1 country187 target enrollmentApril 2009

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Lymphocytic Leukemia
Sponsor: Dartmouth-Hitchcock Medical Center
Enrollment: 187
Locations: 1
Primary Endpoint: To determine the frequency with which CLL cells incubated ex vivo with vincristine undergo rapid interphase apoptosis.
Status: Completed
Last Updated: 6 years ago

The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).

The blood sample will be used in the laboratory to perform studies focusing on Chronic Lymphocytic Leukemia (CLL).

Registry

clinicaltrials.gov

Start Date

April 2009

End Date

March 9, 2018

Last Updated

6 years ago

Study Type

Observational

Sex

All

Sponsor

Responsible Party

Principal Investigator

Christopher H. Lowrey

Professor of Medicine and of Pharmacology and Toxicology

Dartmouth-Hitchcock Medical Center

•Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.

•Patients who have received cytotoxic drug, oral or intravenous steroid or targeted antibody therapy for CLL or other disease process within the past 6 months are excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.